Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
13:32:37 EDT Thu 02 May 2024
Enter Symbol
or Name
USA
CA



News for U:ENTA from 2023-05-03 to 2024-05-02 - 24 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-30 07:00U:ENTANews ReleaseEnanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
2024-04-29 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
2024-04-17 07:00U:ENTANews ReleaseEnanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
2024-03-06 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
2024-02-07 16:01U:ENTANews ReleaseEnanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
2024-02-06 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
2024-01-31 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023
2024-01-04 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference
2024-01-03 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2023-11-22 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Participate at Evercore ISI HealthCONx Conference
2023-11-20 16:01U:ENTANews ReleaseEnanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2023, with Webcast and Conference Call Today at 4:30 p.m. ET
2023-11-13 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Host Conference Call on November 20 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Fourth Quarter and Full Year Ended September 30, 2023
2023-10-13 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Host Virtual Key Opinion Leader Event to Discuss Advances in the Treatment Landscape for Respiratory Syncytial Virus (RSV) and its Proprietary RSV Pipeline
2023-09-17 12:00U:ENTANews ReleaseEnanta Pharmaceuticals to Present Data for EDP-323, its Oral, Once-Daily, L-Protein Inhibitor in Development for the Treatment of Respiratory Syncytial Virus, at the 9th ESWI Influenza Conference
2023-09-07 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Present Data for EDP-938, its Oral, Once-Daily, N-Protein Inhibitor in Development for the Treatment of Respiratory Syncytial Virus, at IDWeek ¢ „ ¢ 2023
2023-08-31 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Participate in Investor Conferences in September
2023-08-07 16:01U:ENTANews ReleaseEnanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter with Conference Call and Webcast Today at 4:30 p.m. ET
2023-07-31 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Host Conference Call on August 7 at 4:30 p.m. ET to Discuss its Financial Results for Its Fiscal Third Quarter Ended June 30, 2023
2023-06-20 07:00U:ENTANews ReleaseEnanta Pharmaceuticals Announces Positive Data From a Phase 1 Clinical Study of EDP-323, an Oral, L-Protein Inhibitor in Development for the Treatment of Respiratory Syncytial Virus
2023-06-07 07:00U:ENTANews ReleaseEnanta Pharmaceuticals Announces Data Presentation at the European Association for the Study of the Liver (EASL) International Liver Congress ¢ „ ¢ 2023
2023-05-31 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Participate at Jefferies Global Healthcare Conference
2023-05-09 07:00U:ENTANews ReleaseEnanta Pharmaceuticals to Participate in Two Investor Conferences in May
2023-05-08 16:01U:ENTANews ReleaseEnanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Conference Call and Webcast Today at 4:30 p.m. ET
2023-05-08 16:01U:ENTANews ReleaseEnanta Pharmaceuticals Reports Positive Topline Results from Phase 2 SPRINT Trial Evaluating EDP-235 in Standard Risk Patients with COVID-19